CUE

Cue Biopharma, Inc.

Company with tickers: CUE

Market Cap

$102.72M

Shares Outstanding

4,045,701

CIK

1645460

CUSIP

22978P106

Website

Visit website

Investor Relations

Investor relations

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2023-12-31	$0	—	—	10-K, filed 2024-03-28
2022-12-31	$200,000	—	—	10-K, filed 2024-03-28
2021-12-31	$750,128	—	—	10-K, filed 2023-03-21
2020-12-31	$271,051	—	—	10-K, filed 2022-03-16
2019-12-31	$91,027	—	—	10-K, filed 2021-03-09

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2023-12-31	$0 Δ	—	—	10-K, filed 2024-03-28
2023-09-30	$0 Δ	—	—	10-Q, filed 2023-11-03
2023-06-30	$0 Δ	—	—	10-Q, filed 2023-08-08
2023-03-31	$0	—	—	10-Q, filed 2023-05-09
2022-12-31	$0 Δ	—	—	10-K, filed 2024-03-28
2022-09-30	$9,000 Δ	—	—	10-Q, filed 2023-11-03
2022-06-30	$0 Δ	—	—	10-Q, filed 2023-08-08
2022-03-31	$191,000	—	—	10-Q, filed 2023-05-09
2021-12-31	$183,128 Δ	—	—	10-K, filed 2023-03-21
2021-09-30	$482,000 Δ	—	—	10-Q, filed 2022-11-14
2021-06-30	$0 Δ	—	—	10-Q, filed 2022-08-04
2021-03-31	$85,000	—	—	10-Q, filed 2022-05-10